177 related articles for article (PubMed ID: 27922077)
1. Mast cell phenotype, TNFα expression and degranulation status in non-small cell lung cancer.
Shikotra A; Ohri CM; Green RH; Waller DA; Bradding P
Sci Rep; 2016 Dec; 6():38352. PubMed ID: 27922077
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
BMC Cancer; 2010 Jun; 10():323. PubMed ID: 20573209
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
BMC Cancer; 2010 Apr; 10():172. PubMed ID: 20429924
[TBL] [Abstract][Full Text] [Related]
4. [EFFECT OF MAST CELL DEGRANULATION BLOCKADE ON THE INFLAMMATION OUTCOME IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY].
Kuzubova NA; Lebedeva ES; Dvorakovskaya IV; Preobrazhenskaya TN; Surkova EA; Titova ON
Ross Fiziol Zh Im I M Sechenova; 2016 Jul; 102(7):825-32. PubMed ID: 30193050
[TBL] [Abstract][Full Text] [Related]
5. Mast cell subpopulations in the synovial tissue of patients with osteoarthritis: selective increase in numbers of tryptase-positive, chymase-negative mast cells.
Buckley MG; Gallagher PJ; Walls AF
J Pathol; 1998 Sep; 186(1):67-74. PubMed ID: 9875142
[TBL] [Abstract][Full Text] [Related]
6. Chymase-positive mast cells in small sized adenocarcinoma of the lung.
Nagata M; Shijubo N; Walls AF; Ichimiya S; Abe S; Sato N
Virchows Arch; 2003 Oct; 443(4):565-73. PubMed ID: 12827514
[TBL] [Abstract][Full Text] [Related]
7. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
Eur Respir J; 2009 Jan; 33(1):118-26. PubMed ID: 19118225
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of human mast cells based on cytokine content.
Bradding P; Okayama Y; Howarth PH; Church MK; Holgate ST
J Immunol; 1995 Jul; 155(1):297-307. PubMed ID: 7602107
[TBL] [Abstract][Full Text] [Related]
9. The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
PLoS One; 2011; 6(7):e21874. PubMed ID: 21799753
[TBL] [Abstract][Full Text] [Related]
10. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell.
Oskeritzian CA; Zhao W; Min HK; Xia HZ; Pozez A; Kiev J; Schwartz LB
J Allergy Clin Immunol; 2005 Jun; 115(6):1162-8. PubMed ID: 15940129
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content.
Weidner N; Austen KF
Pathol Res Pract; 1993 Mar; 189(2):156-62. PubMed ID: 8321743
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human lung mast cells by single cell RNA sequencing.
Rönnberg E; Ravindran A; Mazzurana L; Gong Y; Säfholm J; Lorent J; Dethlefsen O; Orre AC; Al-Ameri M; Adner M; Dahlén SE; Dahlin JS; Mjösberg J; Nilsson G
Front Immunol; 2023; 14():1151754. PubMed ID: 37063885
[TBL] [Abstract][Full Text] [Related]
13. [Distribution of MCT and MCTC in nasal mucosae--relationship with formalin-sensitive mast cells and formalin-resistant mast cells].
Kawabori S; Kanai N
Arerugi; 1993 Aug; 42(8):894-9. PubMed ID: 8250729
[TBL] [Abstract][Full Text] [Related]
14. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies.
Irani AM; Bradford TR; Kepley CL; Schechter NM; Schwartz LB
J Histochem Cytochem; 1989 Oct; 37(10):1509-15. PubMed ID: 2674273
[TBL] [Abstract][Full Text] [Related]
15. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.
Welsh TJ; Green RH; Richardson D; Waller DA; O'Byrne KJ; Bradding P
J Clin Oncol; 2005 Dec; 23(35):8959-67. PubMed ID: 16219934
[TBL] [Abstract][Full Text] [Related]
16. Mast cell phenotypes in the allograft after lung transplantation.
Banga A; Han Y; Wang X; Hsieh FH
Clin Transplant; 2016 Jul; 30(7):845-51. PubMed ID: 27146340
[TBL] [Abstract][Full Text] [Related]
17. Human MCTC type of mast cell granule: the uncommon occurrence of discrete scrolls associated with focal absence of chymase.
Craig SS; Schwartz LB
Lab Invest; 1990 Oct; 63(4):581-5. PubMed ID: 2232709
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction.
Xia HZ; Kepley CL; Sakai K; Chelliah J; Irani AM; Schwartz LB
J Immunol; 1995 May; 154(10):5472-80. PubMed ID: 7730649
[TBL] [Abstract][Full Text] [Related]
19. Accumulation, distribution and phenotype heterogeneity of mast cells (MC) in human brains with neurocysticercosis.
Maślińiska D; Dambska M; Kaliszek A; Maśliński S
Folia Neuropathol; 2001; 39(1):7-13. PubMed ID: 11678351
[TBL] [Abstract][Full Text] [Related]
20. Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation.
Irani AM; Gruber BL; Kaufman LD; Kahaleh MB; Schwartz LB
Arthritis Rheum; 1992 Aug; 35(8):933-9. PubMed ID: 1642658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
